B, C.M., Wej, A.S., Eva, K.H., Caroline, M., & Lars, H.F. (2026). Adipose-derived stem cell uses in orthopaedic surgeries: a scoping review protocol.. BMJ open.
B CM, Wej AS, Eva KH, Caroline M, Lars HF. Adipose-derived stem cell uses in orthopaedic surgeries: a scoping review protocol.. BMJ open. 2026; PMID: 42114874
B CM, Wej AS, Eva KH, et al. Adipose-derived stem cell uses in orthopaedic surgeries: a scoping review protocol.[J]. BMJ open. 2026.
@article{b2026,
author = {Cartuliares Mariana B and Andkjær Stephanie Wej and Kildall Hejbøl Eva and Moos Caroline and Henrik Frich Lars},
title = {Adipose-derived stem cell uses in orthopaedic surgeries: a scoping review protocol.},
journal = {BMJ open},
year = {2026},
note = {PMID: 42114874},
}
TY - JOUR AU - Cartuliares Mariana B AU - Andkjær Stephanie Wej AU - Kildall Hejbøl Eva AU - Moos Caroline AU - Henrik Frich Lars TI - Adipose-derived stem cell uses in orthopaedic surgeries: a scoping review protocol. T2 - BMJ open PY - 2026 AN - PMID:42114874 ER -
Musculoskeletal disorders represent a significant global health burden, frequently leading to chronic pain, functional impairment and disability. Conventional treatment modalities, including rehabilitation, pharmacotherapy and surgical intervention, are often associated with suboptimal outcomes and prolonged recovery. Adipose-derived stem cells (ADSCs) have gained considerable attention due to their regenerative capacity, accessibility and immunomodulatory properties. Preclinical studies of ADSCs have demonstrated promising effects in skeletal muscle regeneration. However, the evidence from human orthopaedic shoulder surgery remains inconclusive. This scoping review aims to map the process of adipose tissue-derived treatments in orthopaedic surgery, especially shoulder surgery.